The Comprehensive Affairs Department of NMPA Solicits Public Comments on “Good Manufacturing Practice (GMP) – Appendix for Cellular Therapy Drugs (Draft for Comments)”
Chapter 1 ScopeArticle 1 [Scope] The cell therapy products (hereinafter referred to as cell products) described in this appendix refer to living cell products of human origin, including cells that hav...
More+
Breakthrough in NK Cell Expansion: Novel K562 Feeder Line Enhances Yield and Purity
A new study published in BMC Biotechnology introduces an innovative engineered K562 feeder cell line (K562-4-1BBL-mbIL-21/IL-15) that has demonstrated remarkable performance in NK cell expansion. Rese...
More+
Cell Therapy CDMO — New Track in Pharmaceutical CXO Industry, the Untapped Area
The era of cell therapy has arrived, bringing hope to complex and intractable diseases, and CDMO has helped it develop rapidlyIn 2021, Fosun Kite's Akilencel injection and WuXi Junuo's Rekioll...
More+
Global Lentiviral Vector CDMO Market to Grow at ~8% CAGR by 2030
Hillgene, a leading CDMO specializing in end-to-end solutions for viral vectors and cell therapies, is committed to supporting global partners with high-quality, scalable, and regulatory-compliant man...
More+
The Comprehensive Affairs Department of NMPA Solicits Public Comments on “Good Manufacturing Practice (GMP) – Appendix for Investigational Drugs (Draft for Comments)”
Chapter I ScopeArticle 1 This Appendix applies to the preparation of drugs for clinical trials (including test drugs and placebos). This Appendix also applies to changes in packaging and labeling of m...
More+
Global Cell and Gene Therapy Market Projected to Reach $39.6 Billion by 2034
The global cell and gene therapy market is projected to experience rapid growth over the next decade, reaching an estimated $39.61 billion by 2034, according to a recent report from Precedence Researc...
More+
Center for Drug Evaluation (CDE) Issued the Notification of “Technical Guideline for the Clinical Risk Management Plan for Marketing Application of Chimeric Antigen Receptor T cell (CAR-T) Therapy Pro
Chimeric antigen receptor CAR-T cells (CAR-T) refer to a type of T cell that can recognize a specific antigen by introducing vectors such as viruses into autologous or allogeneic T cells through gene ...
More+
Study Confirms Safety and Efficiency of Optimized K562 Feeder Cells for NK Cell Expansion
Study Confirms Safety and Efficiency of Optimized K562 Feeder Cells for NK Cell ExpansionA new study published in the Annals of Laboratory Medicine (2025) has reported significant progress in the opti...
More+